Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Major Pharmaceutical Companies Of The World 2002
Download Major Pharmaceutical Companies Of The World 2002 full books in PDF, epub, and Kindle. Read online Major Pharmaceutical Companies Of The World 2002 ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Major Pharmaceutical Companies of the World 2002 by : Graham & Whiteside, Limited
Download or read book Major Pharmaceutical Companies of the World 2002 written by Graham & Whiteside, Limited and published by Graham & Whiteside Limited. This book was released on 2002-01-01 with total page 1400 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis The Truth About the Drug Companies by : Marcia Angell
Download or read book The Truth About the Drug Companies written by Marcia Angell and published by Random House Trade Paperbacks. This book was released on 2005-08-09 with total page 354 pages. Available in PDF, EPUB and Kindle. Book excerpt: During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has become–and argues for essential, long-overdue change. Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers. Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective. The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.
Download or read book Selling Sickness written by Ray Moynihan and published by Greystone Books. This book was released on 2008-09-01 with total page 171 pages. Available in PDF, EPUB and Kindle. Book excerpt: In this hard-hitting indictment of the pharmaceutical industry, Ray Moynihan and Allan Cassels show how drug companies are systematically using their dominating influence in the world of medical science, drug companies are working to widen the very boundaries that define illness. Mild problems are redefined as serious illness, and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. Selling Sickness reveals how expanding the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world. This Canadian edition includes an introduction placing the issue in a Canadian context and describing why Canadians should be concerned about the problem.
Book Synopsis Valuing Pharmaceutical Companies by : Karen Beynon
Download or read book Valuing Pharmaceutical Companies written by Karen Beynon and published by Woodhead Publishing. This book was released on 2000-06-19 with total page 188 pages. Available in PDF, EPUB and Kindle. Book excerpt: The pharmaceutical sector offers some of the most exciting financial and business opportunities today. This essential and practical guide gives you all the tools you need to assess such opportunities. The second edition of the respected Pharmaceutical Equities, it has been thoroughly revised and updated to reflect the changes, especially in life sciences, since the first edition. The book is international in outlook, and explains the rules of the game not just for wise investing, but also for understanding how this uniquely complex and highly regulated business works. The authors explain: HOW to evaluate the technology and research and development, as well as the sales potential of ensuing products WHAT key issues will affect and influence companies in the next few years HOW to balance potential high returns on breakthrough products against accompanying risks The book begins with a look at the global pharmaceutical industry, from its history to the structure of present day companies. The second part explores how to analyse and value pharmaceutical and biotechnology companies. The final part deals with trading itself and looks at share price movement and the main equity markets throughout the world. Both practical and comprehensive, this handbook will be essential reading for investors, analysers and corporate planners - and is the ONLY book which will show you how to actually value pharmaceutical companies.
Book Synopsis Drugs and Drug Policy by : Clayton J. Mosher
Download or read book Drugs and Drug Policy written by Clayton J. Mosher and published by SAGE Publications. This book was released on 2020-11-10 with total page 689 pages. Available in PDF, EPUB and Kindle. Book excerpt: Engaging and thoroughly updated, this text provides a global perspective on the use and regulation of legal and illegal drugs. It examines drug policies in terms of their scope, goals, and effectiveness, as well as the effects of drugs, the patterns and correlates of use, and theories of the causes of drug use.
Download or read book What We've Lost written by Graydon Carter and published by Farrar, Straus and Giroux. This book was released on 2004-09-08 with total page 239 pages. Available in PDF, EPUB and Kindle. Book excerpt: What We've Lost addresses the fragile state of U.S. democracy with a critical review of the Bush administration by one of our leading magazine editors, Graydon Carter. Carter has expressed his deep dissatisfaction with the current state of the nation in his monthly editor's letters in Vanity Fair--which have aroused widespread comment--and now provides a sweeping, painstakingly detailed account of the ruinous effects of this president. The invasion of Iraq, which has proven so costly for the U.S. in lives, dollars, and international standing, is only the tip of the iceberg. It is the war at home, a quiet, covert, and in many ways more lasting and damaging war, that Carter is most wary of. The Bush White House has chipped away at decades' worth of advances in personal rights, women's rights, the economy, and the environment. It is difficult to point to a single element of American society that comes under federal jurisdiction that is not worse off now than it was an administration ago, from civil liberties to the economy, foreign affairs to the environment. Carter discusses these topics and many more with great cogency and specificity, detailing what Bush's radical agenda means for America's future--and its future standing in the world. What We've Lost is not the position paper of a policy wonk or a pundit, but the impassioned argument of a concerned citizen in response to the most precarious political crisis of our time.
Download or read book AIDS and Business written by Saskia Faulk and published by Routledge. This book was released on 2009-05-02 with total page 354 pages. Available in PDF, EPUB and Kindle. Book excerpt: Complete with an impressive collection of complex background and research on HIV/AIDS and a foreword by Dr. Peter Piot, former Executive Director of UNAIDS, this volume collects and critically analyzes a wide range of international case studies, detailing why and how businesses take action on HIV/AIDS and providing a wealth of information on the impact of the pandemic.
Book Synopsis Leading Pharmaceutical Innovation by : Oliver Gassmann
Download or read book Leading Pharmaceutical Innovation written by Oliver Gassmann and published by Springer Science & Business Media. This book was released on 2013-06-05 with total page 184 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies. The authors focus on three sources of pharmaceutical innovation: new management methods, new technologies, and new forms of internationalization. Their findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms such as Novartis and Hoffmann-La Roche.
Book Synopsis The Chemical and Pharmaceutical Industry in China by : G. Festel
Download or read book The Chemical and Pharmaceutical Industry in China written by G. Festel and published by Springer Science & Business Media. This book was released on 2005-12-05 with total page 295 pages. Available in PDF, EPUB and Kindle. Book excerpt: A detailed examination of China’s increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.
Book Synopsis The Global Politics of Pharmaceutical Monopoly Power by : Ellen F. M. 't Hoen
Download or read book The Global Politics of Pharmaceutical Monopoly Power written by Ellen F. M. 't Hoen and published by . This book was released on 2009 with total page 136 pages. Available in PDF, EPUB and Kindle. Book excerpt: In The Global Politics of Pharmaceutical Monopoly Power, researcher and global advocate Ellen 't Hoen explains how new global rules for pharmaceutical patenting impact access to medicines in the developing world. The book gives an account of the current debates on intellectual property, access to medicines, and medical innovation, and provides historical context that explains how the current system emerged. This book supports major policy changes in the management of pharmaceutical patents and the way medical innovation is financed in order to protect public health and, in particular, promote access to essential medicines for all. The Open Society Institute provided support to translate this report into Russian.
Book Synopsis Generic drug entry prior to patent expiration an FTC study by :
Download or read book Generic drug entry prior to patent expiration an FTC study written by and published by DIANE Publishing. This book was released on 2002 with total page 129 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Industrial Marketing written by Mukerjee and published by Excel Books India. This book was released on 2009 with total page 676 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drugs written by Rick Ng and published by John Wiley & Sons. This book was released on 2005-03-11 with total page 368 pages. Available in PDF, EPUB and Kindle. Book excerpt: Statistics show that out of five thousand compounds with initial promise, five will go into human clinical trials, and only one will become an approved drug. This tiny fraction illustrates the huge complexities involved in bringing a drug to market, a process that brings together scientific research, medical ethics, business, and various regulatory agencies. Drugs-From Discovery to Approval presents a clear, step-by-step overview of the entire process. Using simple language, this comprehensive guide introduces basic concepts, then moves on to discuss disease target selection and the discovery processes for both small and large molecule drugs. Subsequent chapters explain preclinical studies, clinical trials, regulatory issues, good manufacturing practices (GMPs), and perspectives on the future. Coverage also includes: * A helpful listing of current FDA and European guidelines * A special section on regulatory authorities and processes in Japan and China * Rich illustrations throughout, including more than ninety figures and tables * Useful appendices on the history of drug discovery and development * Representative examples of drug mechanisms in action Written for professionals in the pharmaceutical industry, and readily accessible for students of pharmacy or medicine and others interested in drug discovery, Drugs-From Discovery to Approval represents a practical and approachable reference on this important process.
Book Synopsis Profile of the International Valve Industry: Market Prospects to 2009 by : Graham Weaver
Download or read book Profile of the International Valve Industry: Market Prospects to 2009 written by Graham Weaver and published by Elsevier. This book was released on 2005-01-20 with total page 266 pages. Available in PDF, EPUB and Kindle. Book excerpt: This revised and updated 3rd edition outlines the structure of the global industry and future trends, highlights issues facing the industrial valve industry, assesses market and technological trends, offers market figures and forecasts to 2009 and identifies the major players. The report also provides a detailed overview of merger and acquisition activity in the industrial valve industry since 2000.
Book Synopsis Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level by : OECD
Download or read book Innovation in Pharmaceutical Biotechnology Comparing National Innovation Systems at the Sectoral Level written by OECD and published by OECD Publishing. This book was released on 2006-03-29 with total page 187 pages. Available in PDF, EPUB and Kindle. Book excerpt: This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain - and makes recommendations advocating an integrated policy approach.
Book Synopsis Microbial Threats to Health by : Institute of Medicine
Download or read book Microbial Threats to Health written by Institute of Medicine and published by National Academies Press. This book was released on 2003-08-25 with total page 397 pages. Available in PDF, EPUB and Kindle. Book excerpt: Infectious diseases are a global hazard that puts every nation and every person at risk. The recent SARS outbreak is a prime example. Knowing neither geographic nor political borders, often arriving silently and lethally, microbial pathogens constitute a grave threat to the health of humans. Indeed, a majority of countries recently identified the spread of infectious disease as the greatest global problem they confront. Throughout history, humans have struggled to control both the causes and consequences of infectious diseases and we will continue to do so into the foreseeable future. Following up on a high-profile 1992 report from the Institute of Medicine, Microbial Threats to Health examines the current state of knowledge and policy pertaining to emerging and re-emerging infectious diseases from around the globe. It examines the spectrum of microbial threats, factors in disease emergence, and the ultimate capacity of the United States to meet the challenges posed by microbial threats to human health. From the impact of war or technology on disease emergence to the development of enhanced disease surveillance and vaccine strategies, Microbial Threats to Health contains valuable information for researchers, students, health care providers, policymakers, public health officials. and the interested public.
Author :United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health Publisher : ISBN 13 : Total Pages :88 pages Book Rating :4.0/5 ( download)
Book Synopsis Project Bioshield Reauthorization Issues by : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Download or read book Project Bioshield Reauthorization Issues written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and published by . This book was released on 2006 with total page 88 pages. Available in PDF, EPUB and Kindle. Book excerpt:
